Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee (“D TTL”), its network of member firms, and their related entities. DT TL and each of its member firms are
legally separate and independent entities. DTTL (also referred to as “Deloitte Global”) does not provide services to clients. Please see www.deloitte.com/about for a more detailed description of DTTL and its member firms.
Deloitte provides audit, consulting, financial advisory, risk management, tax and related services to public and private clients spanning multiple industries. With a globally connected network of member firms in more than
150 countries and territories,
Deloitte brings world-class capabilities and high-quality service to clients, delivering the insights they need to address their most complex business challenges. Deloitte’s more than 200,000 professionals are committed
to becoming the standard of excellence.
This publication contains general information only, and none of Deloitte Touche Tohmatsu Limited, its member firms, or their related entities (collectively the “Deloitte Network”) is, by means of this publication, rendering
professional advice or services. Before making any decision or taking any action that may affect your finances or your business, you should consult a qualified professional adviser. No entity in the Deloitte Network shall
be responsible for any loss whatsoever sustained by any person who relies on this publication.
About Life Sciences and Health Care at Deloitte Touche Tohmatsu Limited
The Deloitte Touche Tohmatsu Limited’s life sciences and health care (LSHC) industry group is composed of more than 12,000 professionals in more than 90 countries. These member firm professionals understand the
complexity of today’s life sciences and health care industry challenges, and provide clients with integrated, comprehensive services that meet their respective needs. In today’s environment, LSHC professionals from across
the Deloitte network help companies to evolve in a changing marketplace, pursue new and innovative solutions, and sustain long-term profitability.
For more information about the DT TL LSHC industry group, email firstname.lastname@example.org or access www.deloitte.com/lifesciencesoutlook.
©2019. For more information, contact Deloitte Touche Tohmatsu Limited.
Organizations displaying higher digital engagement and data
analytics skills appear to have leaders that embrace change and
employees who are willing to get on board with new initiatives.
A greater percentage of digitally-maturing biopharma
companies are exploiting new ways of doing business as
opposed to exploiting organizational competencies.
Collaboration is seen as a key differentiator.
Well-being is emerging as a strategic priority.
CDOs are being recruited from other industries with the
expectation that they could provide fresh perspectives.
Life sciences is competing with other
industries for scarce, tech-savvy talent.
Increasing use of tech—AI, robotic, cognitive—not replacing
workers but shifting the focus onto high-level tasks.